CLINICAL, SUBCLINICAL FEATURES AND RESULTS OF TREATMENT OF CYTOMEGALOVIRUS HEPATITIS IN CHILDREN
##plugins.themes.vojs.article.main##
Tóm tắt
Objective: To describe the clinical and subclinical characteristics of hepatitis in children due to viral cytomegalo-infection and to comment on the results of treatment of hepatitis in children due to viral cytomegalo-infection at the National Children’s Hospital.
Research object and method: Retrospective - prospective study,describing 89 pediatric patients 1-12 months diagnosed with Cytomegalovirus hepatitis and treated at the National Children’s Hospital during the period from 01/01/2020 - 30/06/2022.
Result: 89 patients with CMV hepatitis were followed for 6 months with the following rates: The average age of patients was 2.17 ± 1,596 months, and the ratio of males to females (2.5 : 1), jaundice 86.5%, hepatomegaly 64.0%, feces of silver color 52.8%, dark urine 44.9%, subcutaneous hemorrhage 4.5%. Most transaminases increase slightly and rarely exceed 400U/L. Direct billirubin increased by 91.2%. 66/89 are eligible for antiviral therapy with ganciclovir/ Valganciclovir. Improvement in liver damage was 90.9% and nocomplications accounted for 90.9%.
Conclusion: Most patients have good results after treatment. However, it is necessary to detect and treat in time to limit the severe damage caused by CMV.
##plugins.themes.vojs.article.details##
Từ khóa
hepatitis, Cytomegalovirus
Tài liệu tham khảo
2. Costa JM, PintoSM, Santos-Silva E et al. Incidental hypertransaminasemia in children-a stepwise approach in primary care. Eur. J. Pediatr 2023;182(4):1601-1609.https://doi.org/10.1007/s00431-023-04825-4
3. Khuc Van Lap. Clinical and subclinical studies on Cytomegalovirus disease in children at the National Children’s Hospital. Master’s thesis, Hanoi Medical University, 2009.
4. Huynh Trong Dan. Clinical and subclinical features and progression of CytomegalovirusVIETNAM JOURNAL OF PEDIATRICS 2024, 17, 6 60 hepatitis from 1-12 months at Children’s Hospital 2. Ho Chi Minh City Medical Journal 2007;11(4).
5. Pham Nhat An, Nguyen Van Lam, Vo Manh Hung, Nguyen Phuong Thao. Some clinical epidemiological characteristics of acute cytomegalovirus hepatitis at the National Children’s Hospital 2015-2016. Pediatrics Journal 2015;8(5).
6. Kotton CN, Kumar D, Caliendo Am et al. The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation. Transplantation 2018;102(6):900-931. https://doi.org/10.1097/tp.0000000000002191
7. Çelikel E, Tezer H, Kanik-Yuksek S et al.Evaluation of 98 immunocompetent children with cytomegalovirus infection: importance of neurodevelopmental follow-up. Eur J Pediatr 2015;174(8):1101-1107. https://doi.org/10.1007/s00431-015-2513-9
8. Rafailidis PI, Mourtzoukou EG, Varbobitis IC et al. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 2008;5(47). https://doi.org/10.1186/1743-422X-5-47
9. Oliver SE, Cloud GA, Saschez PJ et al.Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J.Clin. Virol 2009;46 Suppl 4(Suppl 4):S22-S26.https://doi.org/10.1016/j.jcv.2009.08.012
10. Do Van Do. Acute liver injury due to cytomegalovirus infection. Guidelines for diagnosis and treatment of pediatric diseases, Hanoi, 2020:368-370.